We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA LIKELY TO FACE SUIT OVER AUTHORIZED GENERICS RULING
FDA LIKELY TO FACE SUIT OVER AUTHORIZED GENERICS RULING
July 16, 2004
Generic firm Mylan Laboratories will likely sue the FDA over the agency’s refusal to prohibit the marketing and distribution of authorized generics until after the first generic firm’s 180-day exclusivity period has expired.